The 16 systematic reviews of clinical effectiveness prepared for the guideline,

'Osteoporosis: assessment of fracture risk and the prevention of osteoporotic fractures in individuals at high risk' are published as evidence reviews (adverse events reviews are considered separately) in response to the guideline development group's original clinical questions. They have not been formally signed off by the guideline development group, and therefore, have not been clinically interpreted, leading to clinical recommendations. The reviews will form key source material for this to happen, once guideline development is recommenced.

The 16 systematic reviews of clinical effectiveness prepared for the guideline, 'Osteoporosis: assessment of fracture risk and the prevention of osteoporotic fractures in individuals at high risk' are published as evidence reviews. While these reviews help support evidence-based decision making by health practitioners, they do not represent NICE guidance.